Skip to main content
GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India flag India · Delayed Price · Currency is INR
3,252.30
-114.20 (-3.39%)
At close: Jun 17, 2025

BOM:500660 Revenue

In the fiscal year ending March 31, 2025, GlaxoSmithKline Pharmaceuticals had annual revenue of 37.49B INR with 8.56% growth. GlaxoSmithKline Pharmaceuticals had revenue of 9.74B in the quarter ending March 31, 2025, with 4.79% growth.

Revenue
37.49B
Revenue Growth
+8.56%
P/S Ratio
14.84
Revenue / Employee
12.04M
Employees
3,113
Market Cap
556.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202537.49B2.96B8.56%
Mar 31, 202434.54B2.02B6.21%
Mar 31, 202332.52B-263.06M-0.80%
Mar 31, 202232.78B3.52B12.05%
Mar 31, 202129.26B-2.99B-9.27%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,646.93B
HDFC Bank 2,728.47B
Tata Consultancy Services 2,553.24B
Bharti Airtel 1,729.85B
ICICI Bank 2,006.54B
State Bank of India 3,429.39B
Infosys 1,647.16B
Life Insurance Corporation of India 8,901.58B
Revenue Rankings

GlaxoSmithKline Pharmaceuticals News

More News